Figure 2 presents the clinicopathological distribution of men with favorable localized PCa (≤ pT2c, Gleason GG 1, pN0/X, cM0/X, no adjuvant or neoadjuvant therapy, and PSA ≤ 20 ng/ml) after RP, per year of surgery. The gene discussed is KLK3; the disease is posterior cortical atrophy.